Seth Levy

Seth D. Levy



Seth focuses his practice on intellectual property protection, licensing, strategy, and disputes, as well as research transactions and operations, particularly in life sciences and health care. He handles a range of technology and clinical research matters, and advises technology transfer programs at academic and health care institutions. Seth also acts as outside general counsel to technology-driven companies. He is co-chair of the firm’s Life Sciences practice.

What do you focus on?

Technology Transfer

I support tech transfer programs at universities, research institutes and academic medical centers. My experience includes patent procurement and portfolio management, coordinating complex research arrangements, negotiating commercial transactions involving IP, resolving related disputes and coordinating IP enforcement activities. I also advise on the development and expansion of tech transfer programs; the operation of incubators, accelerators and venture funds; and the revision of institutional IP policies to reflect contemporary tech transfer issues. I am intimately familiar with tech transfer operations and the unique environment in which these programs exist.

IP and Research Transactions

I represent academic and health care institutions and life sciences companies in technology and research-driven transactions. I also work with companies in the private sector that do business with these institutions. My work in this area includes drafting and negotiating license agreements, joint research and development agreements, clinical trial agreements, sponsored research agreements, consulting agreements, and a range of other corporate transactions to effectuate deals in the arenas of research, health care, and IP.

Outside General Counsel

I serve as outside general counsel to emerging growth and mid-stage life sciences companies, supporting their businesses in this complex ecosystem. Coordinating with other specialists at the firm when needed, I guide our clients’ fundraising efforts, intellectual property strategy, partnering deals, board governance matters, and their full range of operational issues.

What do you see on the horizon?

Technology transfer offices at academic institutions are developing and deploying increasingly sophisticated programs and service offerings to enhance their institution’s research activities, de-risk their innovations, generate revenue, benefit the public and stimulate economic growth.

I believe technology transfer offices will become more active enforcers of their IP against infringers. I expect these institutions to increasingly leverage litigation to enhance their licensing efforts.

In addition, the COVID-19 pandemic will continue to drive and inform research, development and commercialization efforts throughout the life sciences sector. Practical and efficient deal-making and creative collaborations will be key to addressing worldwide public health issues and to otherwise meet the unique needs of this moment, whether through new treatments, vaccines and medical devices or other technologies such as telemedicine and digital health innovations.

Presentations

  • “Tech Transfer Insights and Trends from the Experts,” AUTM 2021 Western Region Meeting, Virtual event, October 6, 2021
  • “Legal Considerations for use of Human Tissue in Clinical Research,” Foresight 2021, Webinar, October 14, 2021
  • “The essence of Intellectual Property protection for life science startups,” Startup Conversations by Lab Launch, Webinar, May 27, 2021
  • “Regulatory Compliance for Hospital/Startup Partnerships,” KidsX Roundtable, Webinar, February 3, 2021
  • “A Practical Guide to Patents and Trade Secrets for Small Businesses,” LA County Department of Consumer and Business Affairs - Bet Tzedek, Webinar, January 28, 2021
  • “Strategic Approaches to IP Monetization in Tech Transfer,” IP Dealmakers Forum, Webinar, December 3, 2020
  • “Update from the U.S.,” UK Chartered Institute of Patent Attorneys (CIPA), Webinar, November 20, 2020
  • “Anatomy of a License,” USC Stevens Center for Innovation, Webinar, November 10, 2020
  • “Trends and Issues in Sublicensing University IP,” Stanford University Office of Technology Licensing, Webinar, August 5, 2020
  • “Life Sciences Collaborations During the Pandemic,” USC Stevens Center for Innovation and USC Chapter of the National Academy of Inventors, Webinar, July 29, 2020
  • “Startup Investing in a Changing Landscape,” Sustainable Change Alliance, Webinar, July 15, 2020
  • “Collaborations During the Pandemic: Issues and Tips When Considering Partnerships,” BioLabs@NYULangone, Webinar, June 3, 2020
  • “Intellectual Property Issues in Clinical Trials Agreements," UCLA In-House Team, Los Angeles, CA, March 11, 2020
  • “Legal Issues for International Healthtech Companies," Cedars-Sinai Innovation Space, Los Angeles, CA, March 5, 2020
  • “Direct Enforcement of University IP—A Case Study of UC Santa Barbara’s Enforcement of Patent Rights Against Retailers,” AUTM 2019 Eastern Region Meeting, Raleigh, NC, October 3, 2019, and AUTM 2019 Western Region Meeting, Seattle, WA, September 20, 2019
  • “Advocacy 101,” It Gets Better Global Summit, New York, NY, June 27, 2019
  • “Corporate Perspectives on Sourcing Early-Stage Innovation,” USC Innovation Summit, Los Angeles, CA, March 27, 2019
  • “Current Trends in Sublicensing Academic IP,” University of California Fall IP Managers Systemwide Meeting, Santa Cruz, CA, November 6, 2018
  • “Advancing the University’s Mission Through the Monetization of Intellectual Property,” AUTM 2017 Eastern Region Meeting, Boston, MA, October 3, 2017
  • “Preparing Life Sciences Companies for Chinese Opportunities,” Office of Economic Development, Mayor Eric Garcetti, Los Angeles, CA, July 18, 2017
  • “Building an IP Strategy,” LA BioStart Legal Basics Program, Los Angeles, CA, July 14, 2017, August 9, 2018, February 1, 2019, and July 26, 2019
  • “Introduction to Tech Transfer,” LA Bioscience Hub, Los Angeles, CA, June 16, 2017
  • “Navigating Through the Fog: Launching a Startup While Avoiding the Reefs,” UCSB Office of Technology & Industry Alliances, Santa Barbara, CA, May 11, 2017
  • “Legal Issues for Digital Health Companies,” Cedars-Sinai Medical Center Healthcare Accelerator, Los Angeles, CA, February 16, 2017

Representative Experience

Technology Transfer

  • Represent The Regents of the University of California in a groundbreaking patent enforcement campaign to protect its rights in a revolutionary new generation of light bulb technology known as filament LED that was invented by a Nobel laureate-led team at UC Santa Barbara. The campaign includes litigation before the U.S. International Trade Commission, the U.S. District Courts for the Central District of California and Eastern District of New York, and the Patent Trial and Appeal Board at the U.S. Patent and Trademark Office.
  • Represent Cedars-Sinai Medical Center, a nonprofit hospital and multi-specialty academic health science center, on a range of patent prosecution and tech transfer matters, including licensing and spin-off transactions, equity investments, research and technology development collaborations and IP enforcement. A recent matter involved protecting the IP rights in a UV light therapy that combats secondary infections associated with COVID-19 and supporting licensing and third-party research contracting issues to develop a prototype and bring the technology to market.
  • Represent the Eye-Bank for Sight Restoration, a NYC-based tissue bank, in establishing research and license agreements with the Icahn School of Medicine at Mt. Sinai in order for Mt. Sinai researchers to train Eye-Bank personnel to isolate retinal pigment epithelial cells from donated tissue for use in research and other purposes.
  • Represent UC Santa Barbara in several iterations of negotiations with one of its biotech spinoffs. This work included restructuring UC Santa Barbara’s equity and license relationship with the company to address the complexities of the company’s sublicensing partnerships with numerous pharmaceutical companies.
  • Represent Dignity Health, a California-based not-for-profit public-benefit corporation that operates hospitals and ancillary care facilities in several states, in patent prosecution matters as well as a range of other technology transfer issues, including revising its IP policy, supporting its material transfer agreement (MTA) contracting for its internal biobanks and other exchanges of research materials, and representing it in multiple license negotiations for biotech and digital health technologies.
  • Represent the California Institute of Technology (Caltech) with a range of patent prosecution matters.
  • Represent the University of Southern California (USC) with a range of patent prosecution and tech transfer matters.
  • Represented Brown University in revising the template agreements for its tech transfer office.

IP and Research Transactions and Outside General Counsel

  • Represented CHA Biotech Co., Ltd., a Korean-based biotech company, in forming and managing a series of issues through a joint venture called Stem Cell & Regenerative Medicine, Inc., which was established with Ocata Therapeutics, Inc. (f/k/a Advanced Cell Technology, Inc.) before Ocata was acquired by Astellas. The joint venture focused on the development of stem cell technologies.
  • Represent Emmaus Medical, Inc., a specialty pharma company focused on rare and orphan diseases, such as sickle cell disease, for which the company’s Endari™ therapeutic has been approved, in clinical research matters, international pharmaceutical manufacturing, distribution and compassionate use transactions, a collaboration with Kainos Medicine, Inc. for preclinical development of IRAK4 inhibitor as potential anti-cancer drug, and a series of research and licensing transactions with The Lundquist Institute.
  • Serve as outside general counsel to Serimmune Inc., an immune intelligence company developing new approaches for preventing, diagnosing, and treating a range of diseases. Recent matters included a research collaboration with Atreca, using Serimmune’s Serum Epitope Repertoire Analysis (SERA) platform to identify the targets of Atreca’s anti-cancer antibodies, a collaboration with Twist Bioscience to identify and evaluate SARS-CoV-2 therapeutic antibody candidates from Twist’s libraries using Serimmune's SERA platform, and in the launch of a COVID antibody epitope mapping discovery service which provides academic and biopharma researchers with ready access to Serimmune's SERA technology.
  • Represented CMTx Biotech, a clinical-stage biopharmaceutical company, in an exclusive, worldwide license agreement with Galderma Holdings, to develop and commercialize incyclinide, a clinical-stage, orally administered small molecule drug candidate for the treatment of hospitalized COVID-19 patients, among other potential therapeutic indications.
  • Represent Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, in a range of research and licensing transactions with both private-sector and government agencies, for its human and animal health programs. A recent matter involved the company’s collaboration with the Serum Institute of India to rapidly co-develop a live-attenuated COVID-19 vaccine.
  • Represent Iotron Medical, a nuclear technology company, in various matters, including its collaboration with Canadian Isotope Innovations Corp. to produce the radioisotope copper-67 (Cu-67) for new cancer therapies, and various license and research transactions with Argonne National Laboratory.
  • Represent the NARBHA Institute (f/k/a Northern Arizona Regional Behavioral Health Authority, Inc.), a nonprofit organization designated by the Arizona Department of Health Services to plan, implement, fund, monitor, and administer publicly funded comprehensive behavioral health services in Northern Arizona, in establishing a collaboration with TGen North to advance human health through the TGen One Health Collaborative—an initiative that recognizes the interdependence of people, animals, and plants in both the human-built and natural environments.
  • Represented Alphazyme, a developer, manufacturer, and global distributor of molecular biology enzymes, in a sub-licensing agreement with Dyadic International, a global biotechnology company focused on improving and applying its proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market. The sub-licensing agreement includes an equity stake, milestone payments, and royalties upon the commercialization of C1-expressed Alphazyme products.
  • Represented HealthDent Technology International in the sale of its gutta-percha material technology business to Dentsply Sirona, a dental equipment maker and dental consumables producer.
  • Represent El Camino Hospital in connection with clinical trial agreements with various medical device companies.
  • Represented Global Pediatric Surgical Technology and Education Project, Inc. (a/k/a GPSTEP), a California-based nonprofit, in its collaboration with medical device manufacturer, SunMed, LLC, to distribute affordable surgical equipment to pediatric surgeons around the world.
  • Represented OnTo Technology, a developer of advanced battery recycling solutions, in an agreement with Johnson Matthey, a global leader in sustainable technologies, to scale up OnTo’s patented process for the direct recycling of lithium-ion battery scrap. OnTo’s patented Cathode Healing process restores the coating material to be used in making new batteries. It avoids energy-intensive refining processes, significantly increasing manufacturing efficiency, lowering cost and the carbon footprint of batteries used to power electric cars.

Post-expiration patent royalties-Developments since Kimble and practical considerations

Intellectual Property & Technology Law Journal | August 20, 2021

Los Angeles partner Seth Levy and associate Vince Capati, and Washington, DC associate Alexis Grilli, all of the Intellectual Property group, contributed this article analyzing royalties due after a patent’s expiration—considered unlawful per se, in a rule upheld by the Supreme Court in 2015—and what it means for patent owners and licensees.

‘It Gets Better’ gets new leadership

Forbes | May 03, 2021

In this article, Los Angeles Intellectual Property partner Seth Levy discusses the collaborative approach to a leadership change at the It Gets Better Project, where he is stepping down as president and chair of the board of directors to make way for Paul Dien. Seth, a founding member of the LGBTQ+ advocacy organization, will remain on the nonprofit’s board.

Litigation funding as a resource for university patent enforcement

Technology Transfer Tactics | February 22, 2021

Life Sciences practice co-chair and Los Angeles Intellectual Property partner Seth Levy contributed this article on how litigation funding can address some of the more significant challenges for a growing number of universities pursuing patent enforcement campaigns.

Texas uni loses bid to shield cancer vaccine patents from IPRs

Life Sciences Intellectual Property Review | February 18, 2021

Life Sciences practice co-chair and Los Angeles Intellectual Property partner Seth Levy provides third-party commentary on sovereign immunity for disputes involving patents owned by state universities, after the University of Texas lost an appeal to review a ruling preventing it from using sovereign immunity to shield patents from inter partes reviews.

Click here to read the article.

Five minutes with… Seth Levy, Nixon Peabody

World Intellectual Property Review | February 17, 2021

Los Angeles Intellectual Property partner and Life Sciences practice co-chair Seth Levy is featured in this Q&A related to diversity in the intellectual property field, with a particular focus on LGBT+ History Month.

Former AG's file friend-of-the-court brief

KIFI/KIDK News – Idaho | December 22, 2020

This article covers an amicus brief filed with the Ninth Circuit Court of Appeals by three former Idaho attorneys general, detailing why Idaho House Bill 500—which bars transgender women and girls from participating in school sports and subjects all women and girl athletes to the threat of invasive testing—is unconstitutional. In addition to the former AGs, more than 175 athletes joined Athlete Ally and the Women’s Sports Foundation in signing a brief, and the National Women’s Law Center and more than 60 other women’s rights and civil rights groups also filed an amicus brief. Los Angeles Intellectual Property partner Seth Levy and Complex Commercial Disputes partner Sarah Erickson André, and Washington, D.C. Government Investigations & White Collar Defense partner Adam Tarosky are representing the former AGs.

UC Takes Next Step with Filament Light Bulb Case: Manufacturers and ITC

Technology Transfer Tactics | October 22, 2020

This article, covering the University of California’s patent enforcement campaign related to filament LED light bulbs, quotes Los Angeles Intellectual Property partner Seth Levy extensively on a successful initial phase of the campaign, and a recent complaint filed with the U.S. International Trade Commission initiating the second phase. The NP team representing UC is led by Seth and Los Angeles Intellectual Property partner Shawn Hansen.

UC Expands Patent Lawsuit Against Retailers and Manufacturers

Supply Chain Brain | October 05, 2020

The following article covers the U.S. International Trade Commission’s second investigation into leading retailers and suppliers of filament LED lighting products, based on a complaint filed by Nixon Peabody on behalf of the Regents of the University of California (UC). Supply Chain Brain quotes Los Angeles Intellectual Property partner Seth Levy extensively on the expanded patent enforcement campaign. The NP team representing UC is led by Seth and Los Angeles Intellectual Property partner Shawn Hansen.

Standing Apart

Intellectual Property Magazine | October 01, 2020

Intellectual Property partner and Life Sciences Practice co-chair Seth Levy and Intellectual Property counsel Peter Wied, both of Los Angeles, contributed this article, based on their alert, which examines the Gensetix Inc v Baylor College of Medicine case and a recent ruling to allow an infringement case to proceed without the state university patent owner’s involvement.

Nixon says ITC probes retailers in patent infringement case

Bloomberg Law | September 30, 2020

This article covers the U.S. International Trade Commission’s institution of a second investigation into leading retailers and suppliers of filament LED lighting products, based on a complaint NP filed on behalf of the Regents of the University of California (UC). Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen are leading the NP team in UC’s LED patent enforcement campaign.

USITC targets Ikea and GE in bulb investigation

World IP Review | September 30, 2020

The following article covers the U.S. International Trade Commission’s second investigation into leading retailers and suppliers of filament LED lighting products, based on a complaint filed by Nixon Peabody on behalf of the Regents of the University of California (UC). Supply Chain Brain quotes Los Angeles Intellectual Property partner Seth Levy extensively on the expanded patent enforcement campaign. The NP team representing UC is led by Seth and Los Angeles Intellectual Property partner Shawn Hansen.

Investors Back Universities’ Fight for Share of Research Profits

Times Higher Education | September 19, 2020

This article discusses how the LED lighting patent enforcement campaign on behalf of the Regents of the University of California (UC) could chart a path for other universities to protect their innovations, as well as the role of litigation funding in the campaign. The article quotes Los Angeles Intellectual Property partner Seth Levy.

Nixon Peabody Expands Patent Enforcement Campaign for UCSB

Semiconductor Today | September 15, 2020

This article, covering a recent complaint NP filed with the U.S. International Trade Commission on behalf of the Regents of the University of California (UC), quotes Los Angeles Intellectual Property partner Seth Levy on the new litigation and the ongoing LED patent enforcement campaign.

UCSB Expands Patent Enforcement Campaign to Protect Its Filament LED Patents

LEDinside | September 14, 2020

This article covers a recent complaint NP filed with the U.S. International Trade Commission on behalf of the Regents of the University of California (UC), expanding the LED patent enforcement campaign with new litigation against six leading retailers and suppliers of filament LED lighting products. The NP team is led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen.

Nixon Peabody Expands Patent Enforcement Campaign Over LED Technology Developed at UC Santa Barbara

Tech Transfer eNews Blog | September 02, 2020

The following article covers a new complaint filed with the U.S. International Trade Commission on behalf of the Regents of the University of California (UC), quote Los Angeles Intellectual Property partner Seth Levy on the ongoing patent enforcement campaign. The complaint seeks an investigation into the unauthorized importation and sale after importation of UC’s patented filament LED lighting technology by General Electric, Savant Systems, Feit Electric, Home Depot, Ikea, and Satco Products.

University of California Expands Its LED Lamp Patent Infringement Action

LEDs Magazine | September 02, 2020

The following article covers a new complaint filed with the U.S. International Trade Commission on behalf of the Regents of the University of California (UC), quote Los Angeles Intellectual Property partner Seth Levy on the ongoing patent enforcement campaign. The complaint seeks an investigation into the unauthorized importation and sale after importation of UC’s patented filament LED lighting technology by General Electric, Savant Systems, Feit Electric, Home Depot, Ikea, and Satco Products.

UC Files New Complaint in Lightbulb Licensing Dispute

Pacific Coast Business Times | September 01, 2020

This article, covering a new complaint filed with the U.S. International Trade Commission on behalf of the Regents of the University of California (UC), quotes Los Angeles Intellectual Property partner Seth Levy on the ongoing patent enforcement campaign. The complaint seeks an investigation into the unauthorized importation and sale after importation of UC’s patented filament LED lighting technology by General Electric, Savant Systems, Feit Electric, Home Depot, Ikea, and Satco Products.

UC System Asks ITC to Probe Home Depot, Others Over LEDs

Law360 | August 31, 2020

An NP team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen on Monday expanded its groundbreaking patent enforcement campaign on behalf of the Regents of the University of California (UC). The following articles cover the new complaint, filed with the U.S. International Trade Commission, which seeks an investigation into the unauthorized importation and sale after importation of UC’s patented filament LED lighting technology by General Electric, Savant Systems, Feit Electric, Home Depot, Ikea, and Satco Products.

In addition to Seth and Shawn, the NP team includes Washington, DC Intellectual Property partner Evan Langdon; Los Angeles Intellectual Property partners Staci Riordan, Vincent Yip and Peter Wied, and associate Vince Capati; Chicago Intellectual Property associates Paulina Starostka and Angelo Christopher; San Francisco Complex Commercial Disputes associate Tracy Ickes; and Los Angeles patent specialist Jason Moore.

'Edison' Bulb Battle Heats Up With University Targeting GE, Ikea

Bloomberg News | August 31, 2020

An NP team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen on Monday expanded its groundbreaking patent enforcement campaign on behalf of the Regents of the University of California (UC). The following articles cover the new complaint, filed with the U.S. International Trade Commission, which seeks an investigation into the unauthorized importation and sale after importation of UC’s patented filament LED lighting technology by General Electric, Savant Systems, Feit Electric, Home Depot, Ikea, and Satco Products. In addition to Seth and Shawn, the NP team includes Washington, DC Intellectual Property partner Evan Langdon; Los Angeles Intellectual Property partners Staci Riordan, Vincent Yip and Peter Wied, and associate Vince Capati; Chicago Intellectual Property associates Paulina Starostka and Angelo Christopher; San Francisco Complex Commercial Disputes associate Tracy Ickes; and Los Angeles patent specialist Jason Moore.

Universities should consider ITC for IP protection

Tech Transfer Tactics | February 18, 2020

Intellectual Property partners Evan Langdon of Washington, DC, and Shawn Hansen and Seth Levy of Los Angeles co-wrote this article explaining how the U.S. International Trade Commission (ITC) can be a “powerfully effective venue” for patent protection. Evan, Shawn, and Seth are leading the NP team representing the University of California in an investigation pending at the ITC concerning LED lightbulb technology. Read the full article on techtransfercentral.com.

What the University of California case means for retailers and IP in the supply chain

TotalRetail | February 13, 2020

This article analyzes the potential for lasting implications to the global supply chain as a result of the University of California’s (UC) patent enforcement campaign against several retailers selling filament LED lightbulbs. Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen are the lead attorneys representing UC.

Central Coast tech firms, UCSB use litigation to protect patents

Pacific Coast Business Times | February 07, 2020

The article mentions Nixon Peabody’s ongoing representation of the Regents of the University of California in UC Santa Barbara’s patent enforcement matter, noting that a recent $1.1 billion verdict for the California Institute of Technology in another matter could bode well for UC Santa Barbara. Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen are the lead attorneys representing UC.

Think universities are making lots of money from inventions? Think again

The Hechinger Report | January 17, 2020

In this article about the ways universities succeed or fail in monetizing their intellectual property, Los Angeles Intellectual Property partner Seth Levy talks about NP’s patent enforcement work on behalf of the University of California.

University of California targets General Electric in campaign against patent infringement

Tech Transfer Central | January 08, 2020

This article quotes Los Angeles Intellectual Property partner Seth Levy discussing Nixon Peabody’s representation of the University of California, which has sued General Electric as part of its ongoing campaign to enforce its patents on LED lightbulb technology. Seth and Los Angeles Intellectual Property partner Shawn Hansen are leading the NP team.

UCSB adds GE to lawsuit defending LED patents

Pacific Coast Business Times | January 02, 2020

Los Angeles Intellectual Property partner Seth Levy is quoted in this story covering the latest developments in UC Santa Barbara’s patent enforcement campaign to protect its LED lightbulb technology, including the addition of General Electric as a defendant. Seth and Los Angeles Intellectual Property partner Shawn Hansen are leading the NP team.

Michael Nicolas on Longford’s litigation finance focus on universities

Lawdragon | October 08, 2019

In this Q&A, Longford Capital partner Michael Nicolas discusses the litigation financing for Nixon Peabody’s University of California (UC) campaign, led by Los Angeles Intellectual Property partner Seth Levy, to protect UC’s rights related to filament LED technology developed at UC Santa Barbara.

A university lawsuit highlights the interdependence of global supply chains

SupplyChainBrain | September 30, 2019

This article focuses on the impact of Nixon Peabody’s LED lightbulb campaign across the supply chain. Los Angeles Intellectual Property partner Seth Levy is quoted extensively in the piece.

UC lightbulb case may signal more aggressive infringement defense by schools

Technology Transfer Tactics | September 25, 2019

This article features Los Angeles Intellectual Property partner Seth Levy discussing NP’s work representing the University of California in a first-of-its-kind “direct enforcement campaign” designed to protect UC’s patents covering LED lightbulb technology.

ITC investigates University of California complaint against Amazon and other major retailers

IP Watchdog | September 19, 2019

Los Angeles Intellectual Property partner Seth Levy talks about Nixon Peabody’s representation of the University of California in an effort to protect the university’s rights related to filament LED technology developed at UC Santa Barbara. The article also mentions Los Angeles Intellectual Property partner Shawn Hansen as co-lead counsel for UC in this case.

ITC to Probe Amazon, Walmart, Others in LED Patent Case

Law360 | August 29, 2019

This article highlights recent developments in the University of California’s campaign to protect its rights related to filament LED technology developed at UC Santa Barbara. On Wednesday, the U.S. International Trade Commission opened an investigation in response to UC’s complaint, filed in July by the Nixon Peabody team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen.

Ikea, Amazon, and the billion-dollar war over light bulb design

Fast Company | August 02, 2019

This article highlights the University of California’s campaign to protect its rights related to filament LED technology developed at the university. An NP team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen is representing UC in this campaign.

It Gets Better CEO: For LGBTQ Professionals in Big Law, It Is Getting Better

Recorder/Law.com | June 28, 2019

This article, about the progress big law firms have made in support of the LGBTQ community, highlights Los Angeles Intellectual Property partner Seth Levy and his role as chairman and CEO of the It Gets better Project. The story also links to Nixon Peabody’s It Gets Better video.

‘It Gets Better’ CEO Seth Levy on being out in BigLaw

Law360 | June 20, 2019

Los Angeles Intellectual Property partner Seth Levy talks about his involvement with the It Gets Better Project and his experience as an openly gay man in the legal profession. Click here to read the full article.

Contact

Seth D. Levy

Partner
Co-chair, Life Sciences Practice

Los Angeles

Phone: 213-629-6161


Fax: 877-644-1571

University of Southern California Law School, J.D.

Cornell University, B.S., Agricultural & Biological Engineering, cum laude

California

District of Columbia

Idaho

U.S. Court of Appeals, Ninth Circuit

U.S. District Court, Central District of California

U.S. Patent and Trademark Office

  • Managing Intellectual Property—Recognized as an “IP Star” (2020–2021)
  • The Best Lawyers in America© 2020 and 2021 in the field of Biotechnology and Life Sciences Practice
  • Chambers USA: America’s Leading Lawyers for Business for Life Sciences: Corporate/Commercial in California (2009–present)
  • IAM Patent 1000—Ranked as a leading California lawyer for transactions and prosecution (2014–2021)
  • IAM Strategy 300—Ranked as one of the world’s leading IP strategists for licensing and technology transfer (2020-2021)
  • “Best LGBT Lawyers Under 40,” National LGBT Bar Association (2010)
  • Inaugural recipient, Paul Davis Memorial Award for outstanding leadership in pro bono work, University of Southern California Law School (2004)
  • Jack Berman Award of Achievement, recognizing a young lawyer who has provided outstanding service to the legal profession and public, as well as dedication to issues of concern to new and young lawyers, California State Bar (2005)
  • Los Angeles Advisory Board, Biocom
  • Board of Directors, It Gets Better Project
  • Board Member, Better Together Animal Alliance
 blog_symbol

To Live and Law in LA
Subscribe to Live & Law in LA, our podcast on the innovations, industries, and laws impacting Los Angeles and shaping its future.

Back to top